Rising Infertility Rates Driving Growth Of The Chorionic Gonadotropin Market: A Key Factor Shaping the Future of the Chorionic Gonadotropin Market in 2025

Which drivers are expected to have the greatest impact on the over the chorionic gonadotropin market's growth?
The chorionic gonadotropin market is expected to grow due to the rising incidence of fertility issues. Infertility, defined as the inability to conceive after a year of regular, unprotected sex for couples under 35, or six months for those over 35, is increasingly common. This increase is largely attributed to decisions to start families later in life and lifestyle factors like obesity and smoking that adversely affect reproductive health. Chorionic Gonadotropin (hCG), which induces ovulation in women, supports the luteal phase during pregnancy, and boosts testosterone production in men to improve sperm count, is used to deal with these fertility issues. Indeed, the World Health Organization (WHO) reported in April 2023 that about 17.5% of the global adult population, or 1 in 6 people, grapple with infertility, highlighting the necessity for accessible, quality fertility care. Hence, the rise in fertility issues fuels the expansion of the chorionic gonadotropin market. Merely on an upward trend, assisted reproductive technologies are also anticipated to boost the chorionic gonadotropin market growth. Assisted reproductive technologies (ART), medical procedures that aid individuals or couples who can't conceive naturally, are becoming more popular due to high infertility rates, medical advances, postponed family creation, and better accessibility. Chorionic gonadotropin (hCG) features prominently in assisted reproductive technologies by triggering ovulation and supporting the luteal phase post-embryo transfer to ensure successful fertilization and early pregnancy. For instance, in April 2024, as per MJH Life Sciences, the number of ART cycles performed rose, with egg freezing cycles growing from 24,560 in 2021 to 29,803 in 2022. Thus, the surge in assisted reproductive technologies is driving the growth of the chorionic gonadotropin market.

Get Your Chorionic Gonadotropin Market Report Here:
https://www.thebusinessresearchcompany.com/report/chorionic-gonadotropin-global-market-report

What is the future CAGR of the chorionic gonadotropin market, and how will it impact industry expansion?
In recent times, the market for chorionic gonadotropin has seen a consistent rise. The market size, which was at $1,260 million in 2024, is projected to hit $1,340 million by 2025, reflecting a compound annual growth rate (CAGR) of 4.4%. Factors contributing to this growth during the historical period include escalating awareness about hCG amid healthcare professionals and patients, rising application in treating hormonal irregularities, improved affordability, enhancements in healthcare provisions, and a surge in demand for assisted reproductive procedures.

In the upcoming years, the market for chorionic gonadotropin is anticipated to sustain steady growth, reaching up to $1,710 million by 2029 with a 4% compound annual growth rate (CAGR). This projected growth within the expected period can be linked to the increasing occurrence of infertility issues, escalating awareness related to reproductive health, the growing use of assisted reproductive technologies, increased instances of hypogonadism among the elderly population, and the development of the healthcare facilities. Within this same forecast period, noticeable trends include technological progression, advancements in recombinant technology, expansion in assisted reproductive technology, investments into research and development, and innovative drug delivery systems and formulas.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19888&type=smp

What are the most significant trends transforming the chorionic gonadotropin market today?
The primary trend shaping the chorionic gonadotropin market involves the development and focus on innovative solutions like saliva-based pregnancy tests, which enhance convenience, precision, and availability. A saliva-based pregnancy test is a non-intrusive diagnostic method that determines pregnancy by testing a woman's saliva for the presence of human chorionic gonadotropin (hCG), a hormone that's produced in pregnancy. An example of this is the launch of the world's first saliva-based pregnancy test in June 2023 by Salignostics, a biotech company based in Israel. This ground-breaking product permits women to confirm pregnancy using a saliva sample as opposed to urine, detecting the hCG hormone with results obtainable in a short period of 5 to 15 minutes. Salistick facilitates a more relaxed and convenient testing experience, allowing users to conduct the test anywhere and instantly share the news with partners or loved ones.

Which key market segments comprise the chorionic gonadotropin market and drive its revenue growth?
The chorionic gonadotropinmarket covered in this report is segmented -

1) By Type: Human Chorionic Gonadotropin; Animal Chorionic Gonadotropin
2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
3) By Therapeutic Application: Male Hypogonadism; Female Infertility Treatment; Oligospermic Treatment; Cryptorchidism Treatment; Chronic Pain; Other Therapeutic Applications
4) By End User: Research Institutions; Pharmaceutical Companies

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/Discount?id=19888&type=discount

What regions are at the forefront of chorionic gonadotropin market expansion?
North America was the largest region in the chorionic gonadotropin market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the chorionic gonadotropin market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Who are the leading players fueling growth in the chorionic gonadotropin market?
Major companies operating in the chorionic gonadotropin market include Ferring Pharmaceuticals

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/customise?id=19888&type=smp

What Is Covered In The Chorionic Gonadotropin Global Market Report?

•Market Size Forecast: Examine the chorionic gonadotropin market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the chorionic gonadotropin market for a structured understanding.
•Key Players Overview: Analyze major players in the chorionic gonadotropin market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the chorionic gonadotropin market.
•Segment Contributions: Evaluate how different segments drive overall growth in the chorionic gonadotropin market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the chorionic gonadotropin market.
•Industry Challenges: Identify potential risks and obstacles affecting the chorionic gonadotropin market.
•Competitive Landscape: Review strategic developments in the chorionic gonadotropin market, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.